Delivery Order SPE2DB20D1004-SPE2DB25FNJPK
Award Date 7/23/25
Potential Completion Date 7/24/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $25,048.41 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order, effective August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on August 14, 2025, with a ceiling value of $1,143.87. This non-set-aside, competitively awarded contract calls for the delivery of Zepbound 15 mg/0.5 mL pen injections, a GLP-1 receptor agonist medication used in weight management and diabetes treatment. The order is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be...
- The Defense Logistics Agency awarded a $1,525.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injectors with a completion date of August 28, 2025. This delivery order represents a pediatric or small-volume allocation of the GLP-1 receptor agonist medication used for weight management, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award involved no set-aside...
- The Defense Logistics Agency awarded a $2,089.68 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pens, a GLP-1 receptor agonist indicated for weight management. This firm fixed-price delivery order, which will be completed by August 12, 2025, represents a direct purchase under an existing contract vehicle and carries no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,090.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025. This firm fixed-price delivery order is non-competitive and represents a single shipment of the diabetes and weight management medication to support federal healthcare requirements. The contract will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $2,531.68 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Zepbound is a glucagon-like peptide-1 receptor agonist used in diabetes and weight management treatment, and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,050.40 and an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $3,115.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen (0.5 ml), a pharmaceutical product used in diabetes and weight management treatment. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,155.44 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injectors, a medication used in diabetes and weight management treatment. This firm fixed-price delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery...